image dons

I make a donation

ACAPULCO

Prasugrel compared with high-dose clopidogrel in acute coronary syndrome

Terminée

La Grande Journée du Coeur (13 juin 2023)
Attention : plus que quelques places restantes !

La Grande Journée du Coeur (mardi 13 juin 2023)
Les présentations sont en ligne

Colloquium "Rythme et conduction" (23 avril 2024)
Inscrivez-vous !

logo étude

objectif

National, multicentric, trial aiming to evaluate the impact of prasugrel, new platelet inhibitor, in comparison with a loading dose of 900mg clopidogrel and a care dosis of 150mg.

date de réalisation

2006

nombre de patients

56

nombre de centres participants

4 french centers

type de financement

Private (Lilly)

Publication

  • Prasugrel compared with high-dose clopidogrel in acute coronary syndrome. The randomised, double-blind ACAPULCO study
    Gilles Montalescot, Georgios Sideris, Remy Cohen, Catherine Meuleman, Claire Bal dit Sollier, Olivier Barthélémy, Patrick Henry, Pascal Lim, Farzin Beygui, Jean-Philippe Collet, Debra Marshall, Junxiang Luo, Helene Petitjean, Ludovic Drouet
    Publicated dans Thrombosis and Haemostasis

Autres études

+

ANCHOR

En cours


Demonstrate the superiority of an association of VA-ECMO and IABP with an optimal medical treatment compared with an optimal medical treatment only in cardiogenic shock AMI patients
+

EDUC-DAI

En cours


Impact of therapeutic education on the quality of life and the anxiety of patients with a defibrillator.
+

AFLOAT

En cours


To assess if flecainide is more efficient than standard of care (control group) to prevent AF occurrence during the 3 months after PFO closure.